Optimal age for starting lipid lowering treatment

BMJ

Volumn 321, Issue 7261, 2000, Pages 637-

  Simpson, William G ^a   Twomey, Patrick ^b   Marshall, Tom ^c   Jackson, Peter R ^d   Wallis, Erica J ^d   Ramsay, Lawrence E ^d   Vallance, Patrick ^e   Hingorani, Aroon D ^e   Ulrich, Silvia ^e  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

AGE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; ELDERLY CARE; HUMAN; HYPERLIPIDEMIA; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; TREATMENT PLANNING; ADULT; AGED; BLOOD; CORONARY ARTERY DISEASE; MIDDLE AGED; NOTE; RISK;

ADULT; AGE FACTORS; AGED; ANTILIPEMIC AGENTS; CHOLESTEROL; CORONARY DISEASE; HUMANS; MIDDLE AGED; RISK;

EID: 0034625975     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.321.7261.637     Document Type: Letter

References (12)

1. Ulrich S, Hingorani AD, Martin J, Vallance P. What is the optimal age for starting lipid lowering treatment? A mathematical model. BMJ 2000; 320: 1134–1140. (22 April.)
2. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121: 293–298.
3. Wood D, Durrington P, Poulter N, McInnes G, Rees A, Wray R. Joint British guidelines on prevention of coronary heart disease in clinical practice. Heart 1998; 80 (suppl 2): S1–29.
4. Ulrich S, Hingorani AD, Martin J, Vallance P. What is the optimal age for starting lipid lowering treatment? A mathematical model. BMJ 2000; 320: 1134–1140. (22 April.)
5. Norris RM, on behalf of the United Kingdom Heart Attack Study Collaborative Group. Fatality outside hospital from acute coronary events in three British health districts, 1994-5. BMJ 1998; 316: 1065–1070.
6. LaRosa J, He J, Vupputuri S. Effect of statins on risk of coronary disease. A meta-analysis of randomized controlled trials. JAMA 1999; 24: 2340–2346.
7. Ulrich S, Hingorani AD, Martin J, Vallance P. What is the optimal age for starting lipid lowering treatment? A mathematical model. BMJ 2000; 320: 1134–1140. (22 April.)
8. Grover SA, Abrahamowicz M, Joseph L, Brewer C, Coupal L, Suissa S. The benefits of treating hyperlipidaemia to prevent coronary heart disease. Changes in life expectancy and morbidity. JAMA 1992; 267: 816–822.
9. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of coronary heart disease. Lancet 1999; 353: 89–92.
10. Ulrich S, Hingorani AD, Martin H, Vallance P. Lifetime risk of developing coronary heart disease in the UK. Lancet 1999; 353: 925.
11. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994; 308: 367–372.
12. Albert D. Risk in cardiovascular disease. BMJ 2000; 321: 175.